- Home
- GPCR vs DMLP Comparison
GPCR vs DMLP Comparison
Compare GPCR & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- DMLP
- Stock Information
- Founded
- GPCR 2016
- DMLP 2003
- Country
- GPCR United States
- DMLP United States
- Employees
- GPCR N/A
- DMLP N/A
- Industry
- GPCR
- DMLP Oil & Gas Production
- Sector
- GPCR
- DMLP Energy
- Exchange
- GPCR Nasdaq
- DMLP Nasdaq
- Market Cap
- GPCR 1.2B
- DMLP 1.1B
- IPO Year
- GPCR 2023
- DMLP N/A
- Fundamental
- Price
- GPCR $33.00
- DMLP $22.95
- Analyst Decision
- GPCR Strong Buy
- DMLP
- Analyst Count
- GPCR 8
- DMLP 0
- Target Price
- GPCR $69.57
- DMLP N/A
- AVG Volume (30 Days)
- GPCR 838.8K
- DMLP 135.8K
- Earning Date
- GPCR 11-06-2025
- DMLP 11-06-2025
- Dividend Yield
- GPCR N/A
- DMLP 13.97%
- EPS Growth
- GPCR N/A
- DMLP N/A
- EPS
- GPCR N/A
- DMLP 1.13
- Revenue
- GPCR N/A
- DMLP $143,803,000.00
- Revenue This Year
- GPCR N/A
- DMLP N/A
- Revenue Next Year
- GPCR N/A
- DMLP N/A
- P/E Ratio
- GPCR N/A
- DMLP $20.48
- Revenue Growth
- GPCR N/A
- DMLP N/A
- 52 Week Low
- GPCR $13.22
- DMLP $22.55
- 52 Week High
- GPCR $40.06
- DMLP $34.88
- Technical
- Relative Strength Index (RSI)
- GPCR 64.72
- DMLP 32.35
- Support Level
- GPCR $31.50
- DMLP $22.81
- Resistance Level
- GPCR $34.50
- DMLP $23.87
- Average True Range (ATR)
- GPCR 1.72
- DMLP 0.57
- MACD
- GPCR 0.29
- DMLP -0.19
- Stochastic Oscillator
- GPCR 85.30
- DMLP 11.52
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.